About Mundipharma Research
Mundipharma Research is a dynamic organisation wholly dedicated to the research and development of highly effective and innovative medications. Based in Europe (in Cambridge, England, and Limburg, Germany), the company works on behalf of the independent associated companies and in collaboration with pharmaceutical companies to bring medications to both the European and International markets. It was founded in 2006 by bringing together the Cambridge and Limburg research and development entities into one organisation. Total headcount for the company is currently 275 employees.
Mundipharma Research focuses on three main therapeutic areas – Pain, Oncology and Respiratory Diseases. The Mundipharma Research innovation process enables the company to capture and prioritise the most promising ideas. The resulting projects are then run utilising project management techniques which enable Mundipharma Research to achieve objectives swiftly and effectively. The company is proud of these defining attributes.
Mundipharma Research carries out early and late-stage pre-commercial development. This involves pre-clinical research, pharmaceutical development, clinical development (Phase I to Phase IV), Drug Safety & Pharmacovigilance, application for Marketing Authorisation and scientific support to marketed products. Mundipharma Research regularly explores new opportunities and Consumer Health is one of the new key strategic businesses.